Amplifon SpAAMFPF 71 Market Cap is $3,040 Mil as of Jun. 26, 2026. GuruFocus rates AMFPF with a GF Score™ of 71/100 and a GF Value™ of $28.72 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 122 Medical Distribution companies, Amplifon SpA ranks better than 90.16% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Amplifon SpA's share price for the quarter that ended in Mar. 2026 was $10.0875. Amplifon SpA's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 220 Mil. Therefore, Amplifon SpA's market cap for the quarter that ended in Mar. 2026 was $2,219 Mil.
Amplifon SpA's quarterly market cap
declined
from Sep. 2025 ($3,543 Mil) to Dec. 2025 ($3,421 Mil) and
declined
from Dec. 2025 ($3,421 Mil) to Mar. 2026 ($2,219 Mil).
Amplifon SpA's annual market cap
declined
from Dec. 2023 ($6,298 Mil) to Dec. 2024 ($5,859 Mil) and
declined
from Dec. 2024 ($5,859 Mil) to Dec. 2025 ($3,421 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Amplifon SpA's Enterprise Value for Today is $4,746 Mil.
Amplifon SpA (OTCPK:AMFPF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Amplifon SpA Market Cap Related Terms
Amplifon SpA Market Cap Historical Data
* Premium members only.
The historical data trend for Amplifon SpA's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Amplifon SpA's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amplifon SpA Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Amplifon SpA's Market Cap distribution charts can be found below:
* The bar in red indicates where Amplifon SpA's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Amplifon SpA's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amplifon SpA (AMFPF) has a Market Cap of $3,040 Mil as of Jun. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Amplifon SpA and its competitors. According to the industry distribution chart, Amplifon SpA ranks #12 out of 122 companies in the Medical Distribution industry, placing it in the top 9.8%.
Is Amplifon SpA's Market Cap too high?
Amplifon SpA's current Market Cap is $3,040 Mil. The Medical Distribution industry median Market Cap is 137.62. Amplifon SpA's value of $3,040 Mil is 2109.1% above this industry median. Based on the distribution chart, Amplifon SpA ranks #12 out of 122 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Amplifon SpA has a GF Score™ of 71/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Amplifon SpA's Market Cap compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Amplifon SpA ranks #12 out of 122 companies for Market Cap. This places Amplifon SpA in the top 10% of its industry — outperforming the majority of peers. The industry median Market Cap is 137.62. Amplifon SpA's value of $3,040 Mil is 2109.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 137.62, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amplifon SpA's current Market Cap of $3,040 Mil is 2109.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Amplifon SpA and its competitors. For the Medical Distribution industry, the median Market Cap is 137.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amplifon SpA's current Market Cap is $3,040 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amplifon SpA stock overvalued right now?
Based on GuruFocus' analysis, Amplifon SpA (AMFPF) is currently considered Possible Value Trap. The stock's GF Value™ is $28.72, compared to a current price of $11.21 — trading 61% below its estimated fair value. The current Market Cap is $3,040 Mil and 2109.1% above the Medical Distribution industry median of 137.62. Amplifon SpA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Amplifon SpA (AMFPF), the current Market Cap is $3,040 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Amplifon SpA (AMFPF) Overvalued in 2026?
Based on GuruFocus' analysis, Amplifon SpA stock appears to be undervalued.
The current stock price of $11.21 is trading 61% below its estimated GF Value™ of $28.72.
GuruFocus considers Amplifon SpA to be Possible Value Trap.
Key valuation signals for AMFPF:
Market Cap: $3,040 Mil
GF Value™: $28.72 vs. price of $11.21 (61% below fair value)
Industry Position: 2109.1% above the Medical Distribution median (#12 of 122)
No single metric tells the full story. See the AMFPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Amplifon SpA provides customizable hearing solutions and services through a distribution network of network affiliates, corporate shops, franchises, and shop-in-shops. The company operates in three segments based on geography: the Americas; Europe, the Middle East, and Africa; and Asia-Pacific. It generates the majority of its revenue in the EMEA region. It operates under a variety of brands in these regions, including Amplifon, Beter Horen, Maxtone, and Miracle-Ear.
71GF Score
Get the complete analysis for AMFPF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMFPF has been successfully added to your 
